The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 23, 2021
Filed:
Jun. 15, 2018
Applicant:
Beta Pharma, Inc., Wilmington, DE (US);
Inventors:
Michael Nicholas Greco, Lansdale, PA (US);
Michael John Costanzo, Warminster, PA (US);
Michael Alan Green, Easton, PA (US);
Jirong Peng, Mequon, WI (US);
Victoria Lynn Wilde, Montclair, NJ (US);
Don Zhang, Princeton, NJ (US);
Assignee:
BETA PHARMA, INC., Wilmington, DE (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); C07D 403/04 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
C07D 403/04 (2013.01); A61K 31/506 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/38 (2013.01); C07B 2200/13 (2013.01);
Abstract
A pharmaceutical formulation of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide (compound 1), in particular methanesulfonic acid salt thereof, and methods of using the pharmaceutical formulation for the treatment or prevention of diseases or medical conditions mediated through mutated forms of epidermal growth factor receptor (EGFR), such as various cancers, are disclosed.